A Phase II, double-blind, parallel-group comparison study of S-556971 in patients with dyslipidemia

Trial Profile

A Phase II, double-blind, parallel-group comparison study of S-556971 in patients with dyslipidemia

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs KT6 971 (Primary)
  • Indications Dyslipidaemias
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 02 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top